Astron Clinica Pty Ltd
Astron Clinica has developed a unique product suite that enables doctors and skincare specialists to look up to 2mm beneath the surface of the skin.
SIAscopy™, Astron Clinica's patented technology, examines the main components of the skin - haemoglobin, melanin, dermal melanin and collagen - and provide a detailed set of images that add up to a powerful tool in diagnosis and monitoring.
Awarded Frost & Sullivan's 2006 European Technology of the Year Award, Astron Clinica's products have a wide range of clinical and cosmetic uses, from skin cancer diagnosis, to aesthetic applications and providing validation in the development of pharmaceutical and other products for the skin. Our flagship application, MoleView, and latest addition, MoleMate™ have already been clinically proven to help provide a more accurate diagnosis of suspicious lesions, including malignant melanoma.
Beau Visage™ uses SIAscopy to bring to the aesthetics market a consultation, skin imaging and treatment management system. Beau Visage™ identifies blood, melanin and sun damage up to 2mm beneath the surface of the skin, provides objective proof of treatment efficacy, and has the ability to track and manage progress over time.
COSMETRICS™ allows formulators to test and accurately quantify the effect of a product by extracting data from live skin. It presents the perfect solution to the challenge faced by manufacturers in the skin treatment/product markets, whose consumers increasingly demand proof on product claims. Astron Clinica has headquarters in Cambridge, UK, and a wholly-owned Asia Pacific subsidiary in Australia, with global distribution.